SCHEMBL5165572

SCHEMBL5165572

CC1(CCc2ccsc2)COC(=O)N1

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TAAR1 Q96RJ0 1/20 0.37
NAAA Q02083 1/20 0.36
HPGD P15428 2/20 0.35
DRD2 P14416 3/20 0.35
DRD3 P35462 2/20 0.35
S1PR1 P21453 4/20 0.33
MEN1 O00255 1/20 0.33
KDM4A O75164 1/20 0.33
ALDH1A1 P00352 1/20 0.33
MAPT P10636 1/20 0.33
KMT2A Q03164 1/20 0.33
HSD17B10 Q99714 1/20 0.33
KDM4C Q9H3R0 1/20 0.33
L3MBTL1 Q9Y468 1/20 0.33
IDH1 O75874 1/20 0.32
SIGMAR1 Q99720 1/20 0.32
IRAK4 Q9NWZ3 1/20 0.31
CNR1 P21554 1/20 0.31
CNR2 P34972 1/20 0.31
HSD11B1 P28845 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7615636 0.77 S1PR1 (0.42) TAAR1NAAAS1PR1ALDH1A1MAPT
SCHEMBL5166746 0.77 TAAR1 (0.39) TAAR1HPGDMEN1ALDH1A1MAPT
SCHEMBL5170413 0.76 HCAR3 (0.30) S1PR1IRAK4
SCHEMBL5165290 0.72 ALDH1A1 (0.33) ALDH1A1L3MBTL1IRAK4
SCHEMBL386428 0.70 IRAK4 (0.31) S1PR1ALDH1A1IRAK4
SCHEMBL384900 0.70 FPR2 (0.39) HPGDMEN1ALDH1A1MAPTKMT2A
SCHEMBL4462359 0.70 S1PR1 (0.33) S1PR1HSD17B10IRAK4
SCHEMBL7614673 0.69 FPR2 (0.39) TAAR1S1PR1MEN1ALDH1A1MAPT
SCHEMBL7616779 0.69 S1PR1 (0.53) HPGDS1PR1GRM2
SCHEMBL7614630 0.69 S1PR1 (0.69) S1PR1MEN1ALDH1A1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1300405-B1 AMINO ALCOHOL DERIVATIVES SANKYO CO (JP) 2007-04-18 EP disclosed
US-6964976-B2 Amino alcohol derivatives SANKYO COMPANY, LIMITED (JP) 2005-11-15 US disclosed
US-20040132784-A1 Amino alcohol derivatives SANKYO COMPANY, LIMITED (JP) 2004-07-08 US disclosed
US-6723745-B2 PREVENTION OR TREATMENT OF AUTOIMMUNE DISEASE IN WARM BLOODED ANIMAL SANKYO COMPANY, LIMITED (JP) 2004-04-20 US disclosed
US-20030236297-A1 Amino alcohol derivatives SANKYO COMPANY, LIMITED (JP) 2003-12-25 US disclosed
EP-1300405-A1 AMINO ALCOHOL DERIVATIVES Sankyo Company, Limited (JP) 2003-04-09 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030236297-A1 Amino alcohol derivatives CD4, ADH1C, ADH1A TAAR1 32/4885NAAA 2999/4885HPGD 1445/4885
US-20040132784-A1 Amino alcohol derivatives CD4, ADH1C, ADH1A TAAR1 32/4885NAAA 2999/4885HPGD 1445/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.